VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance...
